Neuraxis (NRXS) Ending Cash Balance (2022 - 2026)
Neuraxis' Ending Cash Balance was $4.48 million in Q3 2026, up 2.3% from $4.38 million a year earlier but down 46.2% from the prior quarter.
Powered by 
Analysis
Neuraxis (NRXS) Ending Cash Balance (2022 - 2026) Analysis & Trends
For FY2025, Ending Cash Balance at Neuraxis came in at $4.97 million, up 34.3% from FY2024.
- Ending Cash Balance shows a three-year compound annual growth rate of 169.5% (FY2022 to FY2025).
- In earlier years, Ending Cash Balance was $3.7 million in FY2024, $78,560 in FY2023 (-69.0%) and $253,699 in FY2022.
- Quarterly Ending Cash Balance has moved between $7,820 (Q3 2022) and $8.32 million (Q2 2026) over five years.
- Compared with a year earlier, Ending Cash Balance has increased for four straight quarters, with growth averaging 113.6% over the last five quarters.
- The best year-over-year quarter for Ending Cash Balance over five years was Q1 2026 (growth of 253.0%); the worst was Q4 2023 (a decline of 69.0%).
- Per Business Quant data, NRXS's Ending Cash Balance in the three quarters before Q3 2026 was $8.32 million (Q2 2026), $7.08 million (Q1 2026) and $4.97 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.44 Bn | 236.08 Bn | 5.13 Bn | 5.49 Bn |
| 2 | Abbott Laboratories | 187.98 Bn | 162.45 Bn | 7.39 Bn | 4.05 Bn |
| 3 | Danaher | 163.91 Bn | 143.58 Bn | 3.84 Bn | 5.68 Bn |
| 4 | Intuitive Surgical | 153.75 Bn | 134.17 Bn | 2.08 Bn | 3.02 Bn |
| 5 | Medtronic | 131.67 Bn | 97.80 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 117.84 Bn | 104.03 Bn | 4.25 Bn | 3.27 Bn |
| 7 | Boston Scientific | 64.27 Bn | 59.95 Bn | 3.43 Bn | 797.00 Mn |
| 8 | Edwards Lifesciences | 61.69 Bn | 45.00 Bn | 1.35 Bn | 3.11 Bn |
| 9 | Medline | 51.94 Bn | 49.07 Bn | 1.93 Bn | 2.32 Bn |
| 10 | Neuraxis | 75.94 Mn | 51.10 Mn | 1.76 Mn | 4.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.48 Mn |
| Jun 30, 2026 | 8.32 Mn |
| Mar 31, 2026 | 7.08 Mn |
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 260,885.00 |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 81,752.00 |
| Dec 31, 2023 | 78,560.00 |
| Sep 30, 2023 | 761,249.00 |
| Jun 30, 2023 | 51,440.00 |
| Mar 31, 2023 | 45,463.00 |
| Dec 31, 2022 | 253,699.00 |
| Sep 30, 2022 | 7,820.00 |
| Jun 30, 2022 | 73,646.00 |
API Access
Neuraxis Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NRXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "NRXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NRXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();